Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study.

Not yet recruiting

• Conditions: COVID-19; Surgery-Complications

• Registration Number: NCT05685914
• Lead Sponsor: Peking University Cancer Hospital & Institute

Brief Summary

The goal of this observational study is to determine 30-day mortality and post endoscopic surgery complications in patients with COVID-19 infection who undergo endoscopic surgery.This results will inform future risk stratification, decision making and improve patient's clinical care.This study is an investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-01
• Study First Submitted: 2023-01-12
• Study First Submitted QC: 2023-01-12
• Study First Posted: 2023-01-17
• Last Update Submitted: 2023-05-05
• Last Update Posted: 2023-05-09
• Study Start: 2023-05-31
• Primary Completion: 2023-06-30
• Study Completion: 2023-08-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients undergoing any type of endoscopic surgery in an operating theatre and these patients had COVID-19 infection either at the time of surgery or within 30 days of surgery.

Exclusion Criteria

• If COVID-19 infection is diagnosed >30 days after discharge, the patient should not be included.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
30-day mortality	30 days	Death up to 30-days post surgery

Secondary Outcome Measures

Name	Time	Method
postoperative complications	30 days	Determine postoperative complications one month after surgery.

Trial Locations

Locations (1)

Peking University Cancer Hospital & Institute; 🇨🇳 Beijing, China